Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1942 1
1944 1
1947 1
1948 2
1949 1
1950 2
1951 1
1953 1
1961 1
1964 1
1967 1
1987 1
1993 1
1996 1
1997 1
1998 4
1999 2
2000 1
2002 2
2005 2
2006 2
2007 3
2008 4
2009 5
2010 4
2011 6
2012 11
2013 19
2014 29
2015 29
2016 28
2017 15
2018 11
2019 21
2020 10
2021 10
2022 9
2023 21
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations.
Subbiah V, Sahai V, Maglic D, Bruderek K, Touré BB, Zhao S, Valverde R, O'Hearn PJ, Moustakas DT, Schönherr H, Gerami-Moayed N, Taylor AM, Hudson BM, Houde DJ, Pal D, Foster L, Gunaydin H, Ayaz P, Sharon DA, Goyal L, Schram AM, Kamath S, Sherwin CA, Schmidt-Kittler O, Jen KY, Ricard F, Wolf BB, Shaw DE, Bergstrom DA, Watters J, Casaletto JB. Subbiah V, et al. Among authors: sherwin ca. Cancer Discov. 2023 Sep 6;13(9):2012-2031. doi: 10.1158/2159-8290.CD-23-0475. Cancer Discov. 2023. PMID: 37270847 Free PMC article.
Ketamine Pharmacokinetics.
Kamp J, Olofsen E, Henthorn TK, van Velzen M, Niesters M, Dahan A; Ketamine Pharmacokinetic Study Group. Kamp J, et al. Anesthesiology. 2020 Dec 1;133(6):1192-1213. doi: 10.1097/ALN.0000000000003577. Anesthesiology. 2020. PMID: 32997732 Free article.
Editorial: Publishing in 2023 and Beyond.
Sherwin CM. Sherwin CM. Curr Ther Res Clin Exp. 2023 Jun 2;98:100706. doi: 10.1016/j.curtheres.2023.100706. eCollection 2023. Curr Ther Res Clin Exp. 2023. PMID: 37383483 Free PMC article. No abstract available.
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma.
Kim RD, Sarker D, Meyer T, Yau T, Macarulla T, Park JW, Choo SP, Hollebecque A, Sung MW, Lim HY, Mazzaferro V, Trojan J, Zhu AX, Yoon JH, Sharma S, Lin ZZ, Chan SL, Faivre S, Feun LG, Yen CJ, Dufour JF, Palmer DH, Llovet JM, Manoogian M, Tugnait M, Stransky N, Hagel M, Kohl NE, Lengauer C, Sherwin CA, Schmidt-Kittler O, Hoeflich KP, Shi H, Wolf BB, Kang YK. Kim RD, et al. Among authors: sherwin ca. Cancer Discov. 2019 Dec;9(12):1696-1707. doi: 10.1158/2159-8290.CD-19-0555. Epub 2019 Oct 1. Cancer Discov. 2019. PMID: 31575541 Free article. Clinical Trial.
Clinical pharmacokinetics of inhaled antimicrobials.
Stockmann C, Roberts JK, Yellepeddi VK, Sherwin CM. Stockmann C, et al. Among authors: sherwin cm. Clin Pharmacokinet. 2015 May;54(5):473-92. doi: 10.1007/s40262-015-0250-x. Clin Pharmacokinet. 2015. PMID: 25735634 Review.
242 results